Drilon, Alexander ;
Siena, Salvatore ;
Dziadziuszko, Rafal...
Drilon , A , Siena , S , Dziadziuszko , R , Barlesi , F , Krebs , M G , Shaw , A T , De Braud , F , Rolfo , C , Ahn , M , Wolf , J , Seto , T , Cho , B C , Patel , M R , Chiu , C , John , T , Goto , K , Karapetis , C S , Arkenau , H , Kim , S , Ohe , Y , Li , Y , Chae , Y K , Chung , C H , Otterson , G A , Murakami , H , Lin , C , Tan , D S W , Prenen , H , Riehl , T , Chow-maneval , E , Simmons , B , Cui , N , Johnson , A , Eng , S , Wilson , T R & Doebele , R C 2019 , ' Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials ' , The Lancet Oncology , vol. 21 , no. 2 , pp. 261-270 . https://doi.org/10.1016/S1470-2045(19)30690-4.
,
2019
